Konrad Klinghammer

1.2k total citations
53 papers, 580 citations indexed

About

Konrad Klinghammer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Konrad Klinghammer has authored 53 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Konrad Klinghammer's work include Lung Cancer Treatments and Mutations (16 papers), Head and Neck Cancer Studies (16 papers) and Cancer Genomics and Diagnostics (9 papers). Konrad Klinghammer is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Head and Neck Cancer Studies (16 papers) and Cancer Genomics and Diagnostics (9 papers). Konrad Klinghammer collaborates with scholars based in Germany, Italy and United States. Konrad Klinghammer's co-authors include Ulrich Keilholz, Ingeborg Tinhofer, Jens Hoffmann, Maren Knödler, Volker Budach, Andreas E. Albers, Wolfgang Walther, Damian Rieke, Wilko Weichert and Diana Braunholz and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Cancer Research.

In The Last Decade

Konrad Klinghammer

50 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Konrad Klinghammer Germany	14	310	235	181	133	125	53	580
David Molkentine United States	16	357 1.2×	371 1.6×	186 1.0×	101 0.8×	125 1.0×	30	708
Hoa Q. Trummell United States	13	360 1.2×	305 1.3×	176 1.0×	93 0.7×	94 0.8×	19	620
Xihu Yang China	15	214 0.7×	385 1.6×	65 0.4×	109 0.8×	193 1.5×	35	716
Su Mei Cao China	6	281 0.9×	173 0.7×	86 0.5×	243 1.8×	137 1.1×	19	586
Nina Raulf United Kingdom	9	200 0.6×	482 2.1×	75 0.4×	90 0.7×	250 2.0×	13	696
Jeffrey P. Bruce Canada	9	264 0.9×	240 1.0×	73 0.4×	92 0.7×	154 1.2×	26	517
Goutham Hassan Venkatesh France	12	190 0.6×	237 1.0×	132 0.7×	46 0.3×	253 2.0×	18	533
Changqing Xie United States	14	465 1.5×	165 0.7×	116 0.6×	37 0.3×	119 1.0×	48	745
Varalakshmi Janamanchi United States	3	160 0.5×	273 1.2×	195 1.1×	45 0.3×	62 0.5×	5	498
Xiumei Ma China	12	124 0.4×	181 0.8×	110 0.6×	40 0.3×	108 0.9×	34	473

Countries citing papers authored by Konrad Klinghammer

Since Specialization

Citations

This map shows the geographic impact of Konrad Klinghammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konrad Klinghammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konrad Klinghammer more than expected).

Fields of papers citing papers by Konrad Klinghammer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konrad Klinghammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konrad Klinghammer. The network helps show where Konrad Klinghammer may publish in the future.

Co-authorship network of co-authors of Konrad Klinghammer

This figure shows the co-authorship network connecting the top 25 collaborators of Konrad Klinghammer. A scholar is included among the top collaborators of Konrad Klinghammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konrad Klinghammer. Konrad Klinghammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doll, Christian, Max Heiland, Anne Letsch, et al.. (2025). Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis – A population-based study on German cancer registry data. Oral Oncology. 167. 107384–107384.

Paschold, Lisa, Christoph Schultheiß, Konrad Klinghammer, et al.. (2025). Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer. npj Precision Oncology. 9(1). 272–272.

Stögbauer, Fabian, Korinna Jöhrens, Ingeborg Tinhofer, et al.. (2024). Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristics. Oral Oncology. 149. 106678–106678. 3 indexed citations

Stromberger, Carmen, Max Heiland, Christian Doll, et al.. (2022). Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients. Cancers. 14(2). 423–423. 4 indexed citations

Klinghammer, Konrad, Philipp Jurmeister, Paul Jank, et al.. (2022). Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers. Cancers. 14(11). 2810–2810. 5 indexed citations

Goerling, Ute, Thomas Gauler, Andreas Dietz, et al.. (2021). Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial. Oncology Research and Treatment. 45(6). 319–325. 1 indexed citations

Xu, Qian, Sebastian Ochsenreither, Soldano Ferrone, et al.. (2021). Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts. Cells. 10(3). 517–517. 23 indexed citations

Gruenwald, Viktor, Ullrich Graeven, Philipp Ivanyi, et al.. (2021). 912P Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115). Annals of Oncology. 32. S807–S808. 3 indexed citations

Jesinghaus, Moritz, Katja Steiger, Fabian Stögbauer, et al.. (2020). Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma. British Journal of Cancer. 122(6). 835–846. 13 indexed citations

10.

Tinhofer, Ingeborg, Diana Braunholz, & Konrad Klinghammer. (2020). Preclinical models of head and neck squamous cell carcinoma for a basic understanding of cancer biology and its translation into efficient therapies. PubMed. 5(1). 9–9. 34 indexed citations

11.

Obermayer, Benedikt, Konrad Klinghammer, Sebastian Ochsenreither, et al.. (2020). Distinct immune evasion in APOBEC ‐enriched, HPV ‐negative HNSCC. International Journal of Cancer. 147(8). 2293–2302. 12 indexed citations

12.

Lamping, Mario, Manuela Benary, Serge Leyvraz, et al.. (2020). Support of a molecular tumour board by an evidence-based decision management system for precision oncology. European Journal of Cancer. 127. 41–51. 16 indexed citations

13.

Macchini, Marina, Elena Garralda, Walter Fiedler, et al.. (2020). Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 Gatipotuzumab (GAT) with the anti-EGFR Tomuzotuximab (TO) or Panitumumab in patients with refractory solid tumors. European Journal of Cancer. 138. S5–S6. 1 indexed citations

14.

Klinghammer, Konrad, Thomas Gauler, Andreas Dietz, et al.. (2019). Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108). European Journal of Cancer. 122. 53–60. 19 indexed citations

15.

Qian, Xu, Branko Sinikovic, Frank Schreiber, et al.. (2018). pN status predicts outcomes in surgically treated pT1–pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study. European Archives of Oto-Rhino-Laryngology. 275(11). 2787–2795. 3 indexed citations

16.

Klinghammer, Konrad, Jan-Dirk Raguse, Andreas E. Albers, et al.. (2017). Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer. International Journal of Cancer. 141(6). 1215–1221. 25 indexed citations

17.

Klinghammer, Konrad, et al.. (2017). A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers. International Journal of Cancer. 142(1). 156–164. 2 indexed citations

18.

Klinghammer, Konrad, Wolfgang Walther, & Jens Hoffmann. (2017). Choosing wisely – Preclinical test models in the era of precision medicine. Cancer Treatment Reviews. 55. 36–45. 36 indexed citations

19.

Klinghammer, Konrad, Jan D. Raguse, Andreas E. Albers, et al.. (2015). Employing head and neck cancer patient derived xenografts to inform clinical trial design: Results from combining regorafenib with everolimus.. Journal of Clinical Oncology. 33(15_suppl). e17034–e17034. 2 indexed citations

20.

Tinhofer, Ingeborg, Konrad Klinghammer, Wilko Weichert, et al.. (2011). Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment. Clinical Cancer Research. 17(15). 5197–5204. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact